Next Frontier Advisors has been commissioned by the Wellcome Trust and the Novo Nordisk Foundation to conduct an in-depth landscape review of mucosal immunity as part of the 2022 Challenge Program: “Immunity at Mucosal Surfaces”
Milestone
2.2.e
Mucosal immunity atlas
In progress
Develop a mucosal immunity “atlas”—a comprehensive characterization of mucosal immunity relevant to coronavirus infection, disease, and transmission—to collect and organize information on innate and adaptive coronavirus mucosal immunity that maps responses in different anatomic compartments (i.e., upper versus lower respiratory tract) across different age-groups and geographies.